Hims & Hers and Noom enter synthetic peptide business
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Hims & Hers and Noom are entering the synthetic peptide business, offering compounded treatments for muscle maintenance, intimacy, and longevity. The expansion leverages a new Department of Health and Human Services policy easing enforcement against compounding pharmacies for six unapproved peptides, including BPC-157 and TB-500.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu